|
|
201 Industrial Road San Carlos, CA 94070 USA phone:(650) 631-3100 fax:650.631.3150
|
|
| Symbol |
NKTR |
| Exchange |
Nasdaq |
| Founded |
0 |
| Employees |
668 |
|
|
| www.nektar.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Nektar Therapeutics is a drug delivery products-based company. |
 |
| Management |
| Howard W. Robin, President and Chief Executive Officer; Louis Drapeau, Senior Vice President, Finance and Chief Financial Officer; Nevan Elam, Senior Vice President, Head of the Pulmonary Business Unit; Elizabeth Frisby, Vice President, Human Resources; Hoyoung Huh, M.D., Ph.D., Senior Vice President, Business Development and Marketing; David Johnston, Senior Vice President, Research and Development; Gil M. Labrucherie, General Counsel and Secretary; Truc Le, Senior Vice President of Operations and Corporate Quality; John S. Patton, Ph.D., Co-Founder and Chief Scientific Officer; Christopher J. Searcy, Pharm.D., Senior Vice President, Corporate Development; David Tolley, Senior Vice President, General Manager, Nektar Alabama; Tim Warner, Senior Vice President, Investor Relations & Corporate Affairs |
| |
|
|
|
|
|
|
|
| Keywords |
| drug delivery, pulmonary, lung, inhaler,, DrugDelivery |
|
|
|
| Description |
|
Nektar Therapeutics is a drug delivery products-based company providing a portfolio of technologies and expertise designed to improve drug performance throughout the drug development process. |
 |
| Technology / Differentiation |
| The Company has developed three distinct technology platforms: Nektar Molecule Engineering, Nektar Particle Engineering, and Nektar Delivery Solutions. |
 |
 |
| Competitors / Substitutes / Alternatives |
Aradigm
|
 |
|
|
|
|
|
|